Sun Pharma, Aurobindo recall US market drugs over manufacturing issues
Sun Pharma, Aurobindo recall US market drugs Leading pharmaceutical companies Sun Pharmaceutical Industries and Aurobindo Pharma have initiated recalls of…
Sun Pharma, Aurobindo recall US market drugs Leading pharmaceutical companies Sun Pharmaceutical Industries and Aurobindo Pharma have initiated recalls of…
In the latest regulatory development, APL Healthcare Limited, a subsidiary of pharmaceutical giant Aurobindo Pharma, has garnered attention from the…
Aurobindo Pharma Secures USFDA Nod for Icatibant Injection In a significant stride, Aurobindo Pharma, through its subsidiary Eugia Pharma Specialities,…
Results scheduled for 29th May Prior to the release of quarterly earnings on May 25, attention will be focused on…
Aurobindo Pharma Limited’s wholly owned subsidiary, Eugia Pharma Specialities Limited, has received a final approval from the US Food &…
On January 4, Aurobindo Pharma saw a slight loss amid a weaker market. As of 12:01 pm, Aurobindo Pharma was…